DailyRounds & Marrow : Building India’s Medical Education Ecosystem with ₹363 Cr Profit in FY'25

Introduction

Bengaluru-based healthcare edtech platform DailyRounds delivered an outstanding performance in FY25, reporting ₹363 crore in profit on ₹641 crore operating revenue. At a time when many edtech companies are struggling with declining growth, high customer acquisition costs, and uncertain business models, DailyRounds stands out as one of India’s most profitable and disciplined digital education businesses. Its success underscores the strength of focusing on a niche, high-value segment with persistent demand, strong willingness to pay, and low churn. By targeting medical students and professionals — a community that continuously requires updated knowledge — the company has built a durable and defensible business.

Financial Performance

DailyRounds’ operating revenue grew 13% from ₹568 crore in FY24 to ₹641 crore in FY25, while net profit also increased by 13% year-on-year to ₹363 crore. In addition to core business income, the company generated ₹132 crore from interest on deposits and investments, pushing total revenue to ₹773 crore. The firm reported an EBITDA margin of 57.29% and a Return on Capital Employed (ROCE) of 21.21%, highlighting exceptional operational efficiency. On a unit basis, the company spent just ₹0.46 to earn one rupee of operating revenue — a rare achievement in the edtech sector. These numbers reflect strong pricing power, disciplined spending, and a scalable subscription model that does not rely heavily on aggressive discounting.

From Beginning Till Now: How They Began

Founded in 2014, DailyRounds initially started as an online platform where doctors could discuss real clinical cases and share practical insights from their practice. This community-driven approach helped build trust among medical professionals. Over time, the founders identified a major gap in structured preparation for postgraduate medical entrance examinations. Recognizing this unmet need, they launched Marrow, a comprehensive digital learning platform featuring high-quality video lectures, extensive question banks, mock tests, and performance analytics. This strategic pivot transformed DailyRounds from a peer discussion forum into a full-scale edtech powerhouse with recurring subscription revenue and nationwide reach.

Founders and Leadership

DailyRounds was founded by medical professionals Dr. Deepu Sebin, Dr. Nimmi Cherian, and Dr. Priyaank Choubey. Their firsthand experience navigating India’s demanding medical education system enabled them to design a product tailored to real student needs rather than generic test preparation formats. Their clinical backgrounds also helped establish credibility within the medical community, which proved critical for early adoption. Under their leadership, the company has maintained a strong focus on content quality, academic rigor, and long-term value creation rather than short-term growth hacks.

Cost Structure

On the expense side, legal and professional fees emerged as the largest cost component at ₹91 crore, followed by employee benefit expenses of ₹85 crore. Technology infrastructure costs — including web hosting, payment gateways, advertising, and business promotion — contributed significantly to total expenditure of ₹295 crore in FY25, up from ₹225 crore in FY24. Despite rising costs, the company preserved strong profitability due to its capital-light model, digital delivery, and absence of large physical infrastructure. This lean structure allows DailyRounds to scale efficiently while maintaining healthy margins.

Product Expansion and Market Position

Marrow remains the primary revenue engine, contributing approximately 88% of operating income through subscription plans ranging from three to 36 months. Additional revenue streams include book sales worth ₹75 crore and market research services. Over the years, DailyRounds has established a dominant position in India’s medical postgraduate preparation segment, benefiting from strong brand recognition, high user engagement, and powerful word-of-mouth referrals among students. The platform’s continuous content updates and exam-focused approach create high switching costs for users, strengthening customer retention.

Expansion and Growth Outlook

With total current assets of ₹1,826 crore — including ₹1,756 crore in cash and bank balances — DailyRounds is exceptionally well positioned for future growth. This strong balance sheet provides flexibility to invest in product innovation, global expansion, or strategic acquisitions. However, the rapid emergence of AI-driven learning tools presents both opportunities and challenges. To maintain leadership, the company will need to integrate advanced technologies while preserving the credibility and depth of its content. Given the stable demand for medical education, the long-term outlook remains positive.

Conclusion

DailyRounds’ journey demonstrates how deep domain expertise, a focused target market, and disciplined execution can build a highly profitable startup even in a challenging sector. For founders and investors alike, it offers a compelling blueprint for sustainable scaling in specialized education markets. As India’s healthcare ecosystem expands, platforms like DailyRounds are likely to play a crucial role in shaping the next generation of medical professionals.

👉 Follow Angeltors for deep insights into startup earnings, funding trends, business models, and India’s fastest-growing companies.

GetMyIndia.com Angeltors.coREm RaysVeda.com  LawCanal.com  ABHAYRAY.COM  

GMICapitals.com 

Read more - https://angeltors.com/post/peptris-raises-70-crore-in-series-a-to-accelerate-ai-driven-drug-discovery-55